000 01491 a2200373 4500
005 20250516142009.0
264 0 _c20140530
008 201405s 0 0 eng d
022 _a1433-7339
024 7 _a10.1007/s00520-013-1790-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoo, Kaitlin
245 0 0 _aComparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.
_h[electronic resource]
260 _bSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_cJun 2013
300 _a1785-91 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal, Humanized
_xeconomics
650 0 4 _aBone Neoplasms
_xdrug therapy
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDenosumab
650 0 4 _aDiphosphonates
_xeconomics
650 0 4 _aHumans
650 0 4 _aImidazoles
_xeconomics
650 0 4 _aZoledronic Acid
700 1 _aLam, Kinsey
700 1 _aMittmann, Nicole
700 1 _aKonski, Andre
700 1 _aDennis, Kristopher
700 1 _aZeng, Liang
700 1 _aLam, Henry
700 1 _aChow, Edward
773 0 _tSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
_gvol. 21
_gno. 6
_gp. 1785-91
856 4 0 _uhttps://doi.org/10.1007/s00520-013-1790-y
_zAvailable from publisher's website
999 _c22605631
_d22605631